Stay updated with breaking news from Open Label. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Disease Landscape Insights equips healthcare pioneers with the tools to combat ringworm early stages, providing in-depth diagnostic, treatment, and market...
MELBOURNE, Australia, July 19, 2023 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company)today announces that the first patient has been dosed in a Phase I study of the Company's investigational targeted radiation therapy, TLX250, in combination with a Merck KGaA, Darmstadt, Germany (Merck) DNA-dependent protein kinase (DNA-PK) inhibitor candidate, peposertib (M3814). The study is being conducted in patients with solid tumours expressing carbonic-anhydrase IX (CAIX), a potential pan-cancer target. STARSTRUCK (ClinicalTrials.gov Identifier: NCT05868174) is a Phase Ib,...
CNM-Au8® treatment demonstrated significantly reduced plasma neurofilament light chain levels compared to placebo at 24 weeks Clene plans to discuss the totality of the survival and time-to-event... | June 16, 2023
Expands pipeline with acquisition of new tri-specific antibodiesData readouts for two lead clinical programs expected in 2023 REHOVOT, Israel, May 16, 2023 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. ("Purple
/PRNewswire/ -- AbbVie (NYSE: ABBV) today announced it will present 29 abstracts during the 2023 Digestive Disease Week (DDW) Annual Meeting, May 6-9, 2023,...